[ Lipids--lipoproteins--apolipoproteins--risk markers in atherosclerosis].
Slimane
M N
MN
Laboratoire de Biochimie, Faculté de Médecine, Monastir.
Bouslama
A
A
Maatoug
F
F
Hammami
M
M
Ben Farhat
M H
MH
D000328:Adult; D001053:Apolipoproteins / Q000097:blood* / Q000737:chemistry / Q000187:drug effects; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology*; D015415:Biomarkers / Q000097:blood*; D011345:Fenofibrate / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000737:chemistry / Q000187:drug effects; D008875:Middle Aged; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D001053:Apolipoproteins; D015415:Biomarkers; D008074:Lipoproteins; D011345:Fenofibrate
Lipides--lipoprotéines--apolipoprotéines marqueurs de risque de l'athérosclérose.